BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren Y, Feng Y, Xu K, Yue S, Yang T, Nie K, Xu M, Xu H, Xiong X, Körte F, Barbeck M, Zhang P, Liu L. Enhanced Bioavailability of Dihydrotanshinone I-Bovine Serum Albumin Nanoparticles for Stroke Therapy. Front Pharmacol 2021;12:721988. [PMID: 34531747 DOI: 10.3389/fphar.2021.721988] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang M, Xiang Y, Wang R, Zhang L, Zhang H, Chen H, Luan X, Chen L. Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells. Molecules 2022;27. [PMID: 36431875 DOI: 10.3390/molecules27227774] [Reference Citation Analysis]
2 Yue S, Zhang X, Xu Y, Zhu L, Cheng J, Qiao Y, Dai S, Zhu J, Jiang N, Wu H, Zhang P, Hou Y. The influence of surface charge on the tumor-targeting behavior of Fe3O4 nanoparticles for MRI. J Mater Chem B 2022. [PMID: 34994759 DOI: 10.1039/d1tb02349g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Solanki R, Rostamabadi H, Patel S, Jafari SM. Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: A critical review. Int J Biol Macromol 2021;193:528-40. [PMID: 34655592 DOI: 10.1016/j.ijbiomac.2021.10.040] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]